Salgomed Inc
- Headquarters
- DEL MAR, CA
- Founded
- 2009
- Latest Form D
- $91K, Oct 2015
- Total capital
- $668K
- Federal grants
- $372K
- 2 awards · 2012–2013
- Private capital raised
- $296K
- 2 Form D · last Oct 2015
- 133 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 1 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$91K
- Federal grantHealth and Human S · Phase I · Search Algorithms for Drug Combinations: Extending Approved Cancer Therapies$162K
- Federal grantHealth and Human S · Phase I · Search Algorithms for Drug Combinations: Extending Approved Cancer Therapies$210K
- Private capital raisedForm D · SEC · 1st filing$205K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
Researcher links verified by same-company patents and grants- Giovanni PaternostroResearcherExecutive Officer, DirectorLinked by $372K in grants as PI
- Carlo PiermarocchiExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 1- PendingMethods For Establishing Combinations Of Kinase Inhibitors For The Treatment Of Medical ConditionsUSPTOApplication 14802911
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .